BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Li X, Zhong W, Yang M, Xu M, Sun Y, Ma J, Liu T, Song X, Dong W, Liu X, Chen Y, Liu Y, Abla Z, Liu W, Wang B, Jiang K, Cao H. Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice. EBioMedicine. 2019;48:301-315. [PMID: 31594750 DOI: 10.1016/j.ebiom.2019.09.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 49] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Ivleva EA, Grivennikov SI. Microbiota-driven mechanisms at different stages of cancer development. Neoplasia 2022;32:100829. [PMID: 35933824 DOI: 10.1016/j.neo.2022.100829] [Reference Citation Analysis]
2 Shang J, Guo H, Li J, Li Z, Yan Z, Wei L, Hua Y, Lin L, Tian Y. Exploring the mechanism of action of Sanzi formula in intervening colorectal adenoma by targeting intestinal flora and intestinal metabolism. Front Microbiol 2022;13:1001372. [DOI: 10.3389/fmicb.2022.1001372] [Reference Citation Analysis]
3 de Wit S, Glen C, de Boer RA, Lang NN. Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies. Cardiovasc Res 2022:cvac132. [PMID: 36004495 DOI: 10.1093/cvr/cvac132] [Reference Citation Analysis]
4 Li J, Zhu Y, Yang L, Wang Z. Effect of gut microbiota in the colorectal cancer and potential target therapy. Discov Oncol 2022;13:51. [PMID: 35749000 DOI: 10.1007/s12672-022-00517-x] [Reference Citation Analysis]
5 Sharma T, Gupta A, Chauhan R, Bhat AA, Nisar S, Hashem S, Akhtar S, Ahmad A, Haris M, Singh M, Uddin S. Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis. Cancer Metastasis Rev 2022. [PMID: 35511379 DOI: 10.1007/s10555-022-10026-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Al-Ishaq RK, Koklesova L, Kubatka P, Büsselberg D. Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer. Cancers (Basel) 2022;14:2140. [PMID: 35565269 DOI: 10.3390/cancers14092140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zong S, Ye H, Ye Z, He Y, Zhang X, Ye M. Polysaccharides from Lachnum sp. Inhibited colitis-associated colon tumorigenesis in mice by modulating fecal microbiota and metabolites. Int Immunopharmacol 2022;108:108656. [PMID: 35390743 DOI: 10.1016/j.intimp.2022.108656] [Reference Citation Analysis]
8 Wang Y, Shi Y, Li W, Wang S, Zheng J, Xu G, Li G, Shen X, Yang J. Gut microbiota imbalance mediates intestinal barrier damage in high-altitude exposed mice. FEBS J 2022. [PMID: 35188712 DOI: 10.1111/febs.16409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhou Y, Feng Y, Cen R, Hou X, Yu H, Sun J, Zhou L, Ji Q, Zhao L, Wang Y, Li Q. San-Wu-Huang-Qin decoction Attenuates Tumorigenesis and Mucosal Barrier Impairment in the AOM/DSS Model by Targeting Gut Microbiome. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.153966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Liu X, Jin G, Tang Q, Huang S, Zhang Y, Sun Y, Liu T, Guo Z, Yang C, Wang B, Jiang K, Zhong W, Cao H. Early life Lactobacillus rhamnosus GG colonisation inhibits intestinal tumour formation. Br J Cancer. [DOI: 10.1038/s41416-021-01562-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kim J, Lee HK. Potential Role of the Gut Microbiome In Colorectal Cancer Progression. Front Immunol 2021;12:807648. [PMID: 35069592 DOI: 10.3389/fimmu.2021.807648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
12 Babaei-Jadidi R, Kashfi H, Alelwani W, Karimi Bakhtiari A, Kattan SW, Mansouri OA, Mukherjee A, Lobo DN, Nateri AS. Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids. Oncogenesis 2022;11:4. [PMID: 35046388 DOI: 10.1038/s41389-021-00376-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang M, Zhou B, Cong W, Zhang M, Li Z, Li Y, Liang S, Chen K, Yang D, Wu Z. Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis. Front Pharmacol 2021;12:797605. [PMID: 35002731 DOI: 10.3389/fphar.2021.797605] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Li Y, Hou H, Wang X, Dai X, Zhang W, Tang Q, Dong Y, Yan C, Wang B, Li Z, Cao H. Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling. Front Pharmacol 2021;12:796590. [PMID: 34992541 DOI: 10.3389/fphar.2021.796590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang Z, Lin Y, Liu L, Zheng B, Zhang Y, Zeng H. Effect of Lotus Seed Resistant Starch on Lactic Acid Conversion to Butyric Acid Fermented by Rat Fecal Microbiota. J Agric Food Chem 2022. [PMID: 34989559 DOI: 10.1021/acs.jafc.1c06000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Ahmad Kendong SM, Raja Ali RA, Nawawi KNM, Ahmad HF, Mokhtar NM. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer. Front Cell Infect Microbiol 2021;11:744606. [PMID: 34966694 DOI: 10.3389/fcimb.2021.744606] [Reference Citation Analysis]
17 Hang Z, Lei T, Zeng Z, Cai S, Bi W, Du H. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer. Biomed Pharmacother 2022;145:112343. [PMID: 34864312 DOI: 10.1016/j.biopha.2021.112343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
18 Cai C, Zhang X, Liu Y, Shen E, Feng Z, Guo C, Han Y, Ouyang Y, Shen H. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathog 2021;13:70. [PMID: 34863291 DOI: 10.1186/s13099-021-00466-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Sun Y, Xie R, Li L, Jin G, Zhou B, Huang H, Li M, Yang Y, Liu X, Cao X, Wang B, Liu W, Jiang K, Cao H. Prenatal Maternal Stress Exacerbates Experimental Colitis of Offspring in Adulthood. Front Immunol 2021;12:700995. [PMID: 34804005 DOI: 10.3389/fimmu.2021.700995] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Bolsega S, Bleich A, Basic M. Synthetic Microbiomes on the Rise-Application in Deciphering the Role of Microbes in Host Health and Disease. Nutrients 2021;13:4173. [PMID: 34836426 DOI: 10.3390/nu13114173] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Arnesen H, Hitch TCA, Steppeler C, Müller MHB, Knutsen LE, Gunnes G, Angell IL, Ormaasen I, Rudi K, Paulsen JE, Clavel T, Carlsen H, Boysen P. Naturalizing laboratory mice by housing in a farmyard-type habitat confers protection against colorectal carcinogenesis. Gut Microbes 2021;13:1993581. [PMID: 34751603 DOI: 10.1080/19490976.2021.1993581] [Reference Citation Analysis]
22 Olovo CV, Huang X, Zheng X, Xu M. Faecal microbial biomarkers in early diagnosis of colorectal cancer. J Cell Mol Med 2021. [PMID: 34750964 DOI: 10.1111/jcmm.17010] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
23 Amatya SB, Salmi S, Kainulainen V, Karihtala P, Reunanen J. Bacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory. Cancers (Basel) 2021;13:5450. [PMID: 34771614 DOI: 10.3390/cancers13215450] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Gu J, Sun R, Wang Q, Liu F, Tang D, Chang X. Standardized Astragalus Mongholicus Bunge-Curcuma Aromatica Salisb. Extract Efficiently Suppresses Colon Cancer Progression Through Gut Microbiota Modification in CT26-Bearing Mice. Front Pharmacol 2021;12:714322. [PMID: 34531745 DOI: 10.3389/fphar.2021.714322] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Paley EL. Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging. J Alzheimers Dis Rep 2021;5:571-600. [PMID: 34514341 DOI: 10.3233/ADR-210010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wang N, Ma S, Fu L. Gut Microbiota Dysbiosis as One Cause of Osteoporosis by Impairing Intestinal Barrier Function. Calcif Tissue Int 2021. [PMID: 34480200 DOI: 10.1007/s00223-021-00911-7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Suraya R, Nagano T, Kobayashi K, Nishimura Y. Microbiome as a Target for Cancer Therapy. Integr Cancer Ther 2020;19:1534735420920721. [PMID: 32564632 DOI: 10.1177/1534735420920721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Gheorghe CE, Ritz NL, Martin JA, Wardill HR, Cryan JF, Clarke G. Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls. Gut Microbes 2021;13:1941711. [PMID: 34328058 DOI: 10.1080/19490976.2021.1941711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
29 Hut EF, Radulescu M, Pilut N, Macasoi I, Berceanu D, Coricovac D, Pinzaru I, Cretu O, Dehelean C. Two Antibiotics, Ampicillin and Tetracycline, Exert Different Effects in HT-29 Colorectal Adenocarcinoma Cells in Terms of Cell Viability and Migration Capacity. Curr Oncol 2021;28:2466-80. [PMID: 34287268 DOI: 10.3390/curroncol28040225] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
30 Terasaki M, Uehara O, Ogasa S, Sano T, Kubota A, Kojima H, Tanaka T, Maeda H, Miyashita K, Mutoh M. Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice. Carcinogenesis 2021;42:210-9. [PMID: 32940665 DOI: 10.1093/carcin/bgaa100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
31 Biondi A, Basile F, Vacante M. Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis. World J Gastrointest Oncol 2021; 13(6): 495-508 [PMID: 34163569 DOI: 10.4251/wjgo.v13.i6.495] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Saeed M, Shoaib A, Kandimalla R, Javed S, Almatroudi A, Gupta R, Aqil F. Microbe-based therapies for colorectal cancer: Advantages and limitations. Semin Cancer Biol 2021:S1044-579X(21)00148-6. [PMID: 34020027 DOI: 10.1016/j.semcancer.2021.05.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
33 Salesse L, Lucas C, Hoang MHT, Sauvanet P, Rezard A, Rosenstiel P, Damon-Soubeyrand C, Barnich N, Godfraind C, Dalmasso G, Nguyen HTT. Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model. Cancers (Basel) 2021;13:2060. [PMID: 33923277 DOI: 10.3390/cancers13092060] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
34 Jin G, Tang Q, Ma J, Liu X, Zhou B, Sun Y, Pang X, Guo Z, Xie R, Liu T, Wang B, Cao H. Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood. mSystems 2021;6:e01337-20. [PMID: 33727402 DOI: 10.1128/mSystems.01337-20] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
35 Viennois E, Chassaing B. Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma. Int J Mol Sci 2021;22:2602. [PMID: 33807577 DOI: 10.3390/ijms22052602] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Ladaycia A, Loretz B, Passirani C, Lehr CM, Lepeltier E. Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines. Adv Drug Deliv Rev 2021;170:44-70. [PMID: 33388279 DOI: 10.1016/j.addr.2020.12.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
37 Chen Q, He Z, Zhuo Y, Li S, Yang W, Hu L, Zhong H. Rubidium chloride modulated the fecal microbiota community in mice. BMC Microbiol 2021;21:46. [PMID: 33588762 DOI: 10.1186/s12866-021-02095-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 De Santis S, Liso M, Vacca M, Verna G, Cavalcanti E, Coletta S, Calabrese FM, Eri R, Lippolis A, Armentano R, Mastronardi M, De Angelis M, Chieppa M. Dysbiosis Triggers ACF Development in Genetically Predisposed Subjects. Cancers (Basel) 2021;13:283. [PMID: 33466665 DOI: 10.3390/cancers13020283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Huang QY, Yao F, Zhou CR, Huang XY, Wang Q, Long H, Wu QM. Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes. World J Clin Cases 2020; 8(24): 6213-6228 [PMID: 33392303 DOI: 10.12998/wjcc.v8.i24.6213] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Feng X, Han L, Ma S, Zhao L, Wang L, Zhang K, Yin P, Guo L, Jing W, Li Q. Microbes in Tumoral In Situ Tissues and in Tumorigenesis. Front Cell Infect Microbiol 2020;10:572570. [PMID: 33330121 DOI: 10.3389/fcimb.2020.572570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Qin X, Gu Y, Liu T, Wang C, Zhong W, Wang B, Cao H. Gut mycobiome: A promising target for colorectal cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188489. [PMID: 33278512 DOI: 10.1016/j.bbcan.2020.188489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
42 Cheng Y, Ling Z, Li L. The Intestinal Microbiota and Colorectal Cancer. Front Immunol 2020;11:615056. [PMID: 33329610 DOI: 10.3389/fimmu.2020.615056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 68] [Article Influence: 7.5] [Reference Citation Analysis]
43 Giampieri R, Cantini L, Giglio E, Bittoni A, Lanese A, Crocetti S, Pecci F, Copparoni C, Meletani T, Lenci E, Lupi A, Baleani MG, Berardi R. Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing. Cancers (Basel) 2020;12:E2724. [PMID: 32977434 DOI: 10.3390/cancers12102724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Perillo F, Amoroso C, Strati F, Giuffrè MR, Díaz-Basabe A, Lattanzi G, Facciotti F. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes. Int J Mol Sci 2020;21:E5389. [PMID: 32751239 DOI: 10.3390/ijms21155389] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
45 Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L, Wang Y, Ren J, Yang L, Zhang B, Hu J, Li Q. YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation. Cell Commun Signal 2020;18:113. [PMID: 32677955 DOI: 10.1186/s12964-020-00596-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
46 Kaźmierczak-Siedlecka K, Daca A, Fic M, van de Wetering T, Folwarski M, Makarewicz W. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes 2020;11:1518-30. [PMID: 32453670 DOI: 10.1080/19490976.2020.1764309] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 19.5] [Reference Citation Analysis]
47 Lang M, Baumgartner M, Rożalska A, Frick A, Riva A, Jarek M, Berry D, Gasche C. Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome. Int J Cancer 2020;147:2316-26. [PMID: 32350866 DOI: 10.1002/ijc.33028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
48 Ternes D, Karta J, Tsenkova M, Wilmes P, Haan S, Letellier E. Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism? Trends Microbiol. 2020;28:401-423. [PMID: 32298617 DOI: 10.1016/j.tim.2020.01.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 63] [Article Influence: 18.0] [Reference Citation Analysis]
49 Ma Y, Chen H. Faecal microbiota transplantation, a promising way to treat colorectal cancer. EBioMedicine 2019;49:13-4. [PMID: 31648984 DOI: 10.1016/j.ebiom.2019.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]